​Meet the Scientist Tomas Deierborg

​🧠 Galectin-3 and Alzheimer’s: A New Frontier in Brain Health
🗓️ October 2nd · 6:00 PM CET (Berlin)

​A conversation with Tomas Deierborg & Brian Magierski

​Join us for a compelling online discussion between Tomas Deierborg, neuroscience professor at Lund University, and Brian Magierski, biotech entrepreneur, as they explore a bold new approach to treating Alzheimer’s disease.

​Their conversation centers on galectin-3, a protein that plays a surprising role in brain inflammation and disease progression. Tomas and his team have found that blocking galectin-3 may reduce the harmful brain changes seen in Alzheimer’s — and potentially improve memory and cognition.

​In this session, you’ll hear about:

• ​Why galectin-3 may be a missing link in Alzheimer’s research

• ​What recent animal studies reveal about its potential as a drug target

• ​The journey from lab discovery to real-world treatment

• ​The broader impact for millions of people affected by Alzheimer’s and related diseases

​This event is for anyone interested in brain health, medical innovation, or the future of neurodegenerative disease treatment.

🔬 Speakers:

• ​Brian Magierski – Founding Steward, Cerebrum DAO

• ​Tomas Deierborg, PhD – Project Lead

​🎥 How to Participate:

Watch on YouTube: https://www.youtube.com/@cerebrumdao/streams
Or on X/Twitter: https://x.com/cerebrum_dao